Axa’s X4 Pharmaceuticals XFOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-691,116
| Closed | -$163K | – | 1184 |
|
|
2025
Q1 | $163K | Sell |
691,116
-2,381,027
| -78% | -$563K | ﹤0.01% | 1031 |
|
|
2024
Q4 | $2.25M | Sell |
3,072,143
-4,798
| -0.2% | -$3.52K | 0.01% | 732 |
|
|
2024
Q3 | $2.06M | Buy |
3,076,941
+864
| +0% | +$578 | 0.01% | 735 |
|
|
2024
Q2 | $1.78M | Buy |
3,076,077
+1,705
| +0.1% | +$989 | 0.01% | 786 |
|
|
2024
Q1 | $4.27M | Buy |
3,074,372
+840
| +0% | +$1.17K | 0.01% | 592 |
|
|
2023
Q4 | $2.58M | Sell |
3,073,532
-74,333
| -2% | -$62.3K | 0.01% | 689 |
|
|
2023
Q3 | $3.43M | Sell |
3,147,865
-277,123
| -8% | -$302K | 0.01% | 609 |
|
|
2023
Q2 | $6.64M | Sell |
3,424,988
-971,480
| -22% | -$1.88M | 0.02% | 488 |
|
|
2023
Q1 | $3.82M | Buy |
4,396,468
+34,827
| +0.8% | +$30.3K | 0.01% | 629 |
|
|
2022
Q4 | $4.33M | Buy |
4,361,641
+235,181
| +6% | +$234K | 0.02% | 638 |
|
|
2022
Q3 | $7.06M | Buy |
4,126,460
+2,975,993
| +259% | +$5.09M | 0.03% | 504 |
|
|
2022
Q2 | $1.11M | Sell |
1,150,467
-873
| -0.1% | -$842 | ﹤0.01% | 862 |
|
|
2022
Q1 | $2.01M | Sell |
1,151,340
-479
| -0% | -$838 | 0.01% | 823 |
|
|
2021
Q4 | $2.64M | Buy |
1,151,819
+561,550
| +95% | +$1.29M | 0.01% | 798 |
|
|
2021
Q3 | $3.12M | Buy |
590,269
+21,853
| +4% | +$116K | 0.01% | 776 |
|
|
2021
Q2 | $3.7M | Sell |
568,416
-431
| -0.1% | -$2.8K | 0.01% | 776 |
|
|
2021
Q1 | $4.9M | Sell |
568,847
-148
| -0% | -$1.27K | 0.01% | 717 |
|
|
2020
Q4 | $3.66M | Buy |
568,995
+22,917
| +4% | +$147K | 0.01% | 754 |
|
|
2020
Q3 | $3.7M | Buy |
546,078
+24,544
| +5% | +$166K | 0.01% | 705 |
|
|
2020
Q2 | $4.86M | Buy |
521,534
+19,371
| +4% | +$181K | 0.02% | 624 |
|
|
2020
Q1 | $5.02M | Buy |
+502,163
| New | +$5.02M | 0.03% | 520 |
|